Abstract
The results of the survey of 214 patients with the complicated pregnancy (a preeclampsia, a premature detachment of placenta, antenatal fetal death, miscarriage) in the anamnesis are presented in the article. We determined the level of molecular markers of a thrombophilia (TAT, D-dimer) and aggregation activity of platelets and carried out antithrombotic therapy to these women. It is shown that 47,7 % of such nonpregnant women and pregnant early terms have the high level of D-dimer, TAT - 46,7 %, aggregation activity of platelets - 52,6 %. Determination of the increased levels of molecular markers of a thrombophilia is the indication to application the antithrombotic therapy and allow to control efficiency of this therapy.
Highlights
Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis
■ The results of the survey of 214 patients with the complicated pregnancy in the anamnesis are presented in the article
We determined the level of molecular markers of a thrombophilia (TAT, D-dimer) and aggregation activity of platelets and carried out antithrombotic therapy to these women
Summary
Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis. Показанием к применению противотромботических препаратов у беременных служат выявление генетических маркеров тромбофилии — генетических мутаций и полиморфизмов, способствующих активации системы свертывания крови и/или циркуляции антифосфолипидных антител (АФА) [2]. Ответить на эти вопросы помогает гемостазиологическое исследование с определением уровней молекулярных маркеров тромбофилии и агрегационной активности тромбоцитов.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.